Meningioma 1 antibody (Middle Region)
Quick Overview for Meningioma 1 antibody (Middle Region) (ABIN953469)
Target
See all Meningioma 1 (MN1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 842-872, Middle Region
-
Specificity
- This antibody recognizes Human MN1 (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 842-872 amino acids from the Central region of human MN1.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Alternative Name
- MN1
-
Background
- Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4,22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.Synonyms: Probable tumor suppressor protein MN1, meningioma 1
-
Molecular Weight
- 136001 Da
-
Gene ID
- 4330
-
NCBI Accession
- NP_002421
Target
-